Disease Information & Support


The Word:


Generic name Mitomycin
Pronunciation my-toh-MY-sin
Brand name(s), other common name(s) Mutamycin®
Drug type  Antineoplastic
How the drug is given Intravenously (IV)

Mitomycin is FDA approved to treat people who have advanced adenocarcinoma of the stomach or pancreas in combination with other approved chemotherapeutic agents and as palliative treatment when other treatments have failed. This medication is sometimes prescribed for other uses such as bladder and lung cancer. Mitomycin sometimes causes a temporary loss of hair. After treatment has ended, normal hair growth should return.

Side effects needing medical attention: If mitomycin accidentally seeps out of the vein, it may damage the skin and cause scarring. Your healthcare provider should be notified right away if you notice redness, pain or swelling at the IV site; blood in urine; difficulty breathing or shortness of breath; fever, chills or sore throat; unusual bleeding or bruising; cough; decreased urination; sores in mouth or on lips; swelling of feet or lower legs; bloody vomit; unusual tiredness or fatigue; blurred vision; loss of appetite; nausea and vomiting; drowsiness; headache.

Side effects needing medical attention after stopping this medication: Blood in urine; fever, chills or sore throat; unusual bleeding or bruising; decreased urination; shortness of breath; swelling of feet or lower legs; unusual tiredness
or fatigue.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012